Stocktoria
HAEMONETICS CORP HAE
HAEMONETICS CORP financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.4B | $1.3B | $1.2B | $993.2M | $870.5M | $988.5M | $967.6M | $903.9M | $886.1M |
| Gross profit | $787.6M | $749.0M | $691.5M | $615.1M | $505.5M | $397.8M | $484.5M | $417.5M | $411.9M | $378.5M |
| R&D expense | $59.8M | $62.7M | $54.4M | $50.1M | $46.8M | $32.9M | $30.9M | $35.7M | $39.2M | $37.6M |
| SG&A expense | $442.4M | $436.8M | $429.8M | $376.7M | $340.1M | $275.2M | $282.0M | $273.5M | $316.5M | $301.7M |
| Operating income | $156.7M | $221.8M | $164.9M | $156.0M | $80.8M | $89.7M | $103.4M | $83.5M | $56.2M | -$19.4M |
| Income tax | $30.7M | $44.4M | $34.3M | $26.0M | $20.3M | -$6.6M | $10.6M | $18.6M | $14.1M | -$1.2M |
| Net income | $97.3M | $167.7M | $117.6M | $115.4M | $43.4M | $79.5M | $76.5M | $55.0M | $45.6M | -$26.3M |
| EPS (diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 |
| Operating cash flow | $293.2M | $181.7M | $181.8M | $273.1M | $172.3M | $108.8M | $158.2M | $159.3M | $220.3M | $159.7M |
| Free cash flow | $260.4M | $142.4M | $143.6M | $81.7M | $75.8M | $71.8M | $109.5M | $40.3M | $145.6M | $83.6M |
| Cash & equivalents | $245.4M | $306.8M | $178.8M | $284.5M | $259.5M | $192.3M | $137.3M | $169.4M | $180.2M | $139.6M |
| Inventory | $306.4M | $365.1M | $317.2M | $259.4M | $293.0M | $322.6M | $270.3M | $194.3M | $160.8M | $176.9M |
| Total assets | $2.4B | $2.5B | $2.2B | $1.9B | $1.9B | $1.8B | $1.3B | $1.3B | $1.2B | $1.2B |
| Shareholders' equity | $796.3M | $820.8M | $960.0M | $818.0M | $749.4M | $731.7M | $587.1M | $667.9M | $752.4M | $739.6M |
Growth · year-over-year · Revenue CAGR 4.7%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -2.0% | +4.0% | +12.0% | +17.7% | +14.1% | -11.9% | +2.2% | +7.0% | +2.0% | — |
| Net income growth | -42.0% | +42.6% | +1.9% | +166.1% | -45.4% | +3.8% | +39.1% | +20.7% | — | — |
| EPS growth | -38.1% | +44.5% | +2.2% | +166.7% | -45.8% | +4.7% | +42.3% | +22.4% | — | — |
| Free cash flow growth | +82.8% | -0.8% | +75.7% | +7.9% | +5.6% | -34.4% | +171.5% | -72.3% | +74.1% | +329.6% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-03-28. Facts plus Stocktoria's own computed scores — not investment advice.